Gilead Sciences, Inc. (BIT:1GILD)
96.54
+0.55 (0.57%)
Last updated: Sep 19, 2025, 9:00 AM CET
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of €120.53 billion as of September 22, 2025. Its market cap has increased by 35.57% in one year.
Market Cap
120.53B
Enterprise Value
134.91B
Revenue
24.58B
Ranking
n/a
PE Ratio
22.43
Stock Price
€96.54
Market Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 194.48M to 120.53B, an increase of 61,874.51%. That is a compound annual growth rate of 21.03%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 19, 2025 | 120.53B | 8.40% |
Dec 31, 2024 | 111.19B | 21.76% |
Dec 29, 2023 | 91.32B | -9.36% |
Dec 30, 2022 | 100.75B | 25.80% |
Dec 31, 2021 | 80.09B | 34.14% |
Dec 31, 2020 | 59.70B | -18.50% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Recordati Industria Chimica e Farmaceutica | 10.95B |
DiaSorin | 4.26B |
Amplifon | 3.36B |
EL.En. | 907.29M |
Philogen | 895.37M |
Safilo Group | 651.18M |
GPI S.p.A. | 514.22M |
Garofalo Health Care | 445.19M |